Welch Allyn

EarlySense develops signal-processing technology. The company's lead product, EverOn, a contact-free early detection patient supervision system that measures, records, displays, and alerts heart and respiration rates, as well as bed entries and exits, patient motion, and quality of sleep from under the mattress. EarlySense Ltd. was founded in 2004 and is based in Ramat Gan, Israel with a research and development facility in Israel; and marketing offices in Boston, Massachusetts.

Hubble Telemedical is dedicated to enabling earlier detection of systemic and debilitating diseases that manifest in the retina - the light-sensitive membrane at the back of the eye that transmits visual information to the brain - for more effective treatment and patient care. In addition to eye diseases such as retinopathy, macular degeneration and glaucoma, a range of systemic diseases such cardiovascular and immune diseases can be detected in the retina. Early diagnosis is essential for effective treatment of these diseases. Unfortunately, many at-risk individuals do not receive annual retinal exams due to inconvenience or unavailability. The result is that many individuals go undiagnosed until severe damage has occurred, causing medical complications and increased healthcare costs. They are changing that paradigm. Thanks to their proprietary, award-winning Telemedical Retinal Image Analysis and Diagnosis (TRIAD™) technology, Hubble Telemedical enables screening and diagnosis where and when it is most convenient for the healthcare consumer. They partner with healthcare providers, insurance companies, and employers to bring the power of retinal screening to the consumer. Their services are fully HIPAA-compliant, secure, and easy to use –- and multi-site, peer-reviewed and published clinical studies have demonstrated their ability to dramatically increase annual screening compliance, thereby decreasing overall healthcare costs and, most importantly, improving patients' health. They invite you to contact us to learn more about their services and technology— and how they can work with you to bring the power of retinal image analysis to your organization.

Cardiac Insight Inc. develops body-worn sensing and computing technologies for diagnostic testing in cardiology, respiratory, and other complex disease states. The company offers CardeaScreen, an electrocardiographic device that measures and records the electrical activity of the heart, and helps physicians conducting pre-participation exams to identify athletes with abnormal heart conditions. Its products are used by pediatricians, primary care physicians, cardiologists, sports team physicians, professional trainers, and community screening organizations. The company was incorporated in 2008 and is based in Bellevue, Washington.

Cyrano Sciences, is focused on providing chemical and biological sensors and software solutions.